Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pozen Inc (POZN)

Pozen Inc (POZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pozen Inc 1414 RALEIGH ROAD SUITE 400 CHAPEL HILL NC 27517

www.pozen.com P: 919-913-1030

Description:

Pozen Inc. is pharmaceutical development company committed to building a portfolio of products with significant commercial potential in select therapeutic areas. Its initial area of focus is migraine, where the company have built a portfolio of four product candidates through a combination of innovation and in-licensing. Its lead product candidate is MT 100, which the company is developing as an oral first-line therapy for the treatment of migraine.

Key Statistics

Overview:

Market Capitalization, $K 208,720
Shares Outstanding, K 32,420
Annual Sales, $ 32,390 K
Annual Net Income, $ 19,670 K
Last Quarter Sales, $ 5,820 K
Last Quarter Net Income, $ -8,150 K
60-Month Beta 1.65
% of Insider Shareholders 15.20%
% of Institutional Shareholders 66.17%

Growth:

1-Year Return -13.91%
3-Year Return 4.03%
5-Year Return 1.37%
5-Year Revenue Growth 0.62%
5-Year Earnings Growth -360.87%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.25 on 11/09/15
Latest Earnings Date 03/14/16
Earnings Per Share ttm -0.54
EPS Growth vs. Prev Qtr 50.00%
EPS Growth vs. Prev Year -225.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Most Recent Dividend 1.750 on 12/31/13
Dividend Payable Date 12/30/13
Dividend Payout Ratio 0.00%

POZN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 0.00
Price/Earnings to Growth N/A
Return-on-Equity % -44.07%
Return-on-Assets % -36.76%
Profit Margin % 60.73%
Debt/Equity 0.00
Price/Sales 7.92
Price/Cash Flow 0.00
Price/Book N/A
Book Value/Share 0.90
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar